[The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)]
- PMID: 214045
- DOI: 10.1007/BF00447363
[The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)]
Abstract
The in vivo stimulation of lymphocytes was used to assess cell mediated immunity to herpes simplex virus (hsv) in patients with recurrent skin eruptions caused by this virus. 1. Phytohaemagglutinine stimulation of lymphocytes was normal in all examined patients. There was no difference in the PHA-stimulation of a control group. 2. Specific lymphocytes stimulation by hsv-antigen may be regarded as a sensitive parameter for a previous hsv-infection. 3. In 6 patients with severe infections of hsv type I or II and more than 10 recurrences per year we found a lower stimulation than in patients with occasionally (up to 10 times a year) skin eruptions. 4. An antigen used as vaccine, Lupidon H, ten times more concentrated (100,000 EID/ml) than the commercially available antigen is able to stimulate lymphocytes in vitro.
Similar articles
-
Association of Herpes simplex virus (HSV) with cervical cancer by lymphocyte reactivity with HSV-1 and HSV-2 antigens.Am J Epidemiol. 1979 Aug;110(2):141-7. doi: 10.1093/oxfordjournals.aje.a112798. Am J Epidemiol. 1979. PMID: 223438
-
Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.J Immunol. 1977 Mar;118(3):1095-1102. J Immunol. 1977. PMID: 191524
-
[Immunotherapy of recurrent Herpes simplex diseases].Hautarzt. 1979 Jun;30(6):287-91. Hautarzt. 1979. PMID: 378899 Review. German.
-
Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.J Immunol. 1984 Nov;133(5):2736-42. J Immunol. 1984. PMID: 6207243
-
Infection with herpes-simplex viruses 1 and 2. II.N Engl J Med. 1973 Oct 4;289(14):719-25. doi: 10.1056/NEJM197310042891404. N Engl J Med. 1973. PMID: 4353782 Review.
Cited by
-
Vaccination for herpes simplex genitalis.Br J Vener Dis. 1979 Apr;55(2):121-2. doi: 10.1136/sti.55.2.121. Br J Vener Dis. 1979. PMID: 445121 Free PMC article.
-
In vitro studies on the human cellular immune response to commercially available herpes simplex antigens.Arch Dermatol Res. 1980;268(3):247-55. doi: 10.1007/BF00404285. Arch Dermatol Res. 1980. PMID: 7212769